Even in the late stages of development, it's not without hope.
As long as it is treated with the Hongmeng Potion, there is still a survival rate of over 50%.
The reason for the other 50% mortality rate is not because the Hongmeng Potion cannot improve the genes.
It's because when the disease progresses to the late stage, it causes many complications, which weakens the body and leads to death.
Now, Hongmeng Pharmaceutical Company, a subsidiary of Light Blue Starry Sky Group, is developing a new Hongmeng No.2 Potion.
According to some information revealed by officials, the Hongmeng No.2 Potion has the effect of enhancing human functions.
It not only cures late-stage patients whose bodies are weakened by diseases, but also enhances the physical fitness of healthy individuals, theoretically reaching the standards of national athletes.
